Liver Diseases: all 2,094 studies
Page 19 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Classical Procedure Versus Intrahepatic Glisson's ApproachStatus unknownNCT01567631Not applicable
- Fish Oil for Patients With Liver Disease Due to Parenteral NutritionTerminatedNCT01565278Phase 3
- TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus PerfusionTerminatedNCT01564095Phase 2/3
- Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic FunctionCompletedNCT01563562Phase 1
- Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaStatus unknownNCT01556815Phase 2
- Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver DiseaseCompletedNCT01556113Not applicable
- Glucomannan Effects on Children With Non-alcoholic Fatty Liver DiseaseCompletedNCT01553500Phase 2
- Ursodeoxycholic Acid in Bariatric SurgeryCompletedNCT01548079Not applicable
- Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in ChildrenCompletedNCT01547910Phase 2
- Clinical Study of Lyophilized Plasma in Patients With Liver DiseaseWithdrawnNCT01547078Phase 2
- Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus AtorvastatinStatus unknownNCT01544751Not applicable
- S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT01533324Phase 2
- Pharmacokinetics of AGO178 in Participants With Liver ImpairmentCompletedNCT01531309Phase 1
- Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy VolunteersCompletedNCT01529294Phase 1
- HIV Accelerated Liver Disease in UgandaCompletedNCT01524562
- A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic FunctionCompletedNCT01516047Phase 1
- Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT01511523Not applicable
- A Novel Pharmacotherapy for Alcoholism and Alcohol Liver DiseaseCompletedNCT01504295Phase 2
- Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult SubjectsCompletedNCT01493869Phase 1
- Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without DiabetesCompletedNCT01492283
- Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular CarcinomaCompletedNCT01490203
- Pulmonary Embolism After Liver ResectionStatus unknownNCT01486511
- Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver CirrhosisStatus unknownNCT01483248Phase 1/2
- Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty LiverCompletedNCT01477307
- Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT01472120
- Myfortic, Prograf, and Corticosteroids in de Novo Liver TransplantationCompletedNCT01467011
- INR-Triggered Transfusion In GI Bleeders From ERTerminatedNCT01461889Phase 3
- Study of Psychological Defense Mechanisms Used by Liver Transplant PatientsCompletedNCT01458756
- A Study to Evaluate the Pharmacokinetics of AFQ056 in Subjects With Hepatic Impairment Compared to Healthy SubjectsCompletedNCT01456663Phase 1
- Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver DiseaseCompletedNCT01446276Not applicable
- Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic FunctionCompletedNCT01443481Phase 1
- Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.CompletedNCT01437969
- Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or RecoveryStatus unknownNCT01435421
- Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance ImagingStatus unknownNCT01434056
- Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy SubjectsCompletedNCT01433458Phase 1
- A PK and Safety Study in Subjects With Hepatic ImpairmentCompletedNCT01431833Phase 1
- The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery ProgrammeStatus unknownNCT01429779Phase 4
- PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic FunctionCompletedNCT01429337Phase 1
- Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver InjuryApproved for marketingNCT01425567
- Everolimus in de Novo Liver Transplantation: a Multicentre Randomized StudyStatus unknownNCT01423708Phase 2
- Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver TransplantationCompletedNCT01421212Phase 1/2
- Pharmacokinetics of Favipiravir in Volunteers With Hepatic ImpairmentCompletedNCT01419457Phase 1
- Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT01418027Phase 3
- Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver CirrhosisStatus unknownNCT01412593Phase 1/2
- Integrated Stepped Care for Unhealthy Alcohol Use in HIVCompletedNCT01410123Not applicable
- Comparison Between Epidural and Bilateral Paravertebral Blocks in Liver ResectionCompletedNCT01407666Not applicable
- Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 DiabetesCompletedNCT01399645Phase 2
- Use of N-Acetylcysteine During Liver ProcurementCompletedNCT01394497Phase 2
- Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver DiseaseCompletedNCT01393678Phase 3
- Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver DiseaseCompletedNCT01393665Phase 2
- Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)CompletedNCT01390766
- Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular CarcinomaCompletedNCT01390194
- G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver DiseaseCompletedNCT01384565Phase 3
- Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)CompletedNCT01381432
- Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT01373554Phase 2
- Effect of Dietary Macronutrient CompositionCompletedNCT01371396Not applicable
- A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous ConivaptanCompletedNCT01370148Phase 1
- Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic FunctionCompletedNCT01367522Phase 1
- Meta-analyses of Fructose and Cardiometabolic RiskStatus unknownNCT01363791
- Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver DiseaseStatus unknownNCT01360879
- Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic DysfunctionCompletedNCT01358565Phase 1
- Dietary Protein and Hepatic Fat AccumulationCompletedNCT01354626Not applicable
- Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)CompletedNCT01354405
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV InfectionCompletedNCT01350648
- Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver DiseaseStatus unknownNCT01350167Not applicable
- The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver FunctionCompletedNCT01338714Phase 3
- Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver DiseasesStatus unknownNCT01337440Phase 4
- Hepatocyte Matrix Implant Study IndonesiaStatus unknownNCT01335568Phase 1
- Mechanism and the Effect of Midodrine on Portal Pressures in Patients With CirrhosisWithdrawnNCT01331785Not applicable
- Influence of Routinely Adding Ultrasound Screening in Medical DepartmentCompletedNCT01331187Not applicable
- Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver LesionsStatus unknownNCT01329458
- Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver DiseaseCompletedNCT01327443Not applicable
- Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic SteatohepatitisCompletedNCT01324414
- A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic ImpairmentCompletedNCT01319279Phase 1
- Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver!CompletedNCT01317576Not applicable
- An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423CompletedNCT01316679
- Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver DiseaseCompletedNCT01315795Phase 2/3
- Association Between Non-alcoholic Fatty Liver Disease and Iron StatusStatus unknownNCT01307254
- Effect of Fructose Reduction on Non-alcoholic Fatty Liver Disease (NAFLD) and Metabolic Syndrome in Overweight ChildrenStatus unknownNCT01306396Not applicable
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsCompletedNCT01303549Phase 4
- Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver DiseaseCompletedNCT01284049Not applicable
- Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse ElastographyCompletedNCT01283230
- Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary AtherosclerosisStatus unknownNCT01282892
- Volatile Organic Compounds (VOCs) and Liver DiseasesStatus unknownNCT01279356
- The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver DiseaseCompletedNCT01277237Phase 3
- A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT01277094Phase 1
- Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic ImpairmentCompletedNCT01271387Phase 1
- A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.CompletedNCT01266941Phase 1
- The Role of Resistance Training in Non Alcoholic Fatty Liver DiseaseCompletedNCT01264198Not applicable
- Determination of the Effect of Extreme Dietary Carbohydrate Restriction on Hepatic Glucose ProductionCompletedNCT01262326Not applicable
- Selenoprotein P and Non-alcoholic Fatty Liver DiseaseCompletedNCT01257685
- Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound GuidingStatus unknownNCT01256138
- Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.Status unknownNCT01256125
- Minimization of IntraLipid Versus OmegavenStatus unknownNCT01247012Phase 2/3
- Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic HepatopathyStatus unknownNCT01246388
- Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver DiseaseCompletedNCT01241227
- Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver DiseaseCompletedNCT01237574
- GSK1349572 Hepatic Impairment StudyCompletedNCT01231529Phase 1
- A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) FunctionCompletedNCT01222455Phase 1
- Liver Regeneration After Liver ResectionStatus unknownNCT01220986